Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 116,169 | 94,014 | 93,678 | 78,254 | 78,332 |
| Depreciation Amortization | 47,984 | 40,958 | 29,816 | 24,369 | 18,427 |
| Income taxes - deferred | 5,634 | -9,075 | -6,135 | -4,477 | N/A |
| Accounts receivable | -10,266 | -25,535 | -6,583 | -9,300 | -5,162 |
| Accounts payable and accrued liabilities | -4,327 | 5,851 | 4,352 | 4,901 | -5,791 |
| Other Working Capital | -33,511 | -1,010 | -10,236 | 10,745 | -13,637 |
| Other Operating Activity | 21,625 | 29,921 | 4,934 | 12,060 | 23,210 |
| Operating Cash Flow | $143,308 | $135,124 | $109,826 | $116,552 | $95,379 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 35,000 | 30,655 | 44,261 | 48,896 |
| PPE Investments | -89,971 | -65,138 | -44,415 | -21,448 | -29,065 |
| Net Acquisitions | 3,134 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -4,758 | -89,884 | -25,220 | -7,604 | -53,942 |
| Other Investing Activity | -4,758 | -90,990 | -26,940 | -10,219 | -56,582 |
| Investing Cash Flow | $-91,595 | $-121,128 | $-40,700 | $12,594 | $-36,751 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 79,550 | 72,389 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -356 |
| Common Stock Issued | 16,360 | 20,941 | 20,922 | 18,841 | 19,376 |
| Common Stock Repurchased | -132,342 | -118,387 | -105,711 | -123,769 | -129,191 |
| Other Financing Activity | 5,642 | 6,870 | 8,530 | -2,057 | 0 |
| Financing Cash Flow | $-30,790 | $-18,187 | $-76,259 | $-106,985 | $-110,171 |
| Exchange Rate Effect | -2,415 | 2,885 | 1,648 | -2,166 | 1,757 |
| Beginning Cash Position | 60,360 | 61,666 | 67,151 | 47,156 | 96,942 |
| End Cash Position | 78,868 | 60,360 | 61,666 | 67,151 | 47,156 |
| Net Cash Flow | $18,508 | $-1,306 | $-5,485 | $19,995 | $-49,786 |
| Free Cash Flow | |||||
| Operating Cash Flow | 143,308 | 135,124 | 109,826 | 116,552 | 95,379 |
| Capital Expenditure | -89,971 | -65,138 | -44,415 | -24,199 | -29,065 |
| Free Cash Flow | 53,337 | 69,986 | 65,411 | 92,353 | 66,314 |